Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.28
-0.56 (-3.54%)
At close: May 15, 2026, 4:00 PM EDT
15.20
-0.08 (-0.52%)
After-hours: May 15, 2026, 7:42 PM EDT

Aurinia Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
298.3283.06235.13175.51134.0345.61
Revenue Growth (YoY)
20.62%20.38%33.97%30.95%193.89%-9.01%
Cost of Revenue
30.632.6728.2514.155.661.09
Gross Profit
267.7250.39206.89161.37128.3744.51
Selling, General & Admin
103.48101.79172.03195.04196.37173.54
Research & Development
34.2332.5120.7949.6444.9951.14
Other Operating Expenses
5.4911.1818.768.38-1.520.57
Total Operating Expenses
143.21145.48211.57253.06239.84225.25
Operating Income
124.49104.91-4.69-91.69-111.47-180.74
Interest Income
13.5213.5716.97175.120.53
Interest Expense
-4.28-4.33-4.84-2.78--
Total Non-Operating Income (Expense)
9.249.2412.1414.225.120.53
Pretax Income
133.73114.167.45-77.47-106.35-180.21
Provision for Income Taxes
-164.48-173.051.70.551.830.76
Net Income
298.21287.25.75-78.02-108.18-180.97
Net Income to Common
298.21287.25.75-78.02-108.18-180.97
Net Income Growth
648.43%4893.08%----
Shares Outstanding (Basic)
133134143143142129
Shares Outstanding (Diluted)
138139146143142129
Shares Change (YoY)
-5.03%-5.13%2.07%0.93%9.70%9.20%
EPS (Basic)
2.262.140.04-0.54-0.76-1.40
EPS (Diluted)
2.172.070.04-0.54-0.76-1.40
EPS Growth
675.00%5075.00%----
Shares Outstanding
130.77132.32140.88143.83142.27141.6
Free Cash Flow
166.64135.4144.11-34.18-79.82-158
Free Cash Flow Growth
23.07%206.99%----
Free Cash Flow Per Share
1.210.980.30-0.24-0.56-1.22
Gross Margin
89.74%88.46%87.99%91.94%95.77%97.61%
Operating Margin
41.73%37.06%-1.99%-52.24%-83.17%-396.31%
Profit Margin
99.97%101.47%2.45%-44.45%-80.71%-396.81%
FCF Margin
55.87%47.84%18.76%-19.47%-59.55%-346.44%
EBITDA
143.9124.3614.76-80.04-108.76-177.97
EBITDA Margin
48.24%43.94%6.28%-45.61%-81.15%-390.25%
EBIT
124.49104.91-4.69-91.69-111.47-180.74
EBIT Margin
41.73%37.06%-1.99%-52.24%-83.17%-396.31%
Effective Tax Rate
-122.99%-151.58%22.77%-0.71%-1.72%-0.42%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q